|Articles|April 1, 2016
- Pharmaceutical Executive-04-01-2016
- Volume 36
- Issue 4
Pharmaceutical Executive, April 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Closing the Gaps in Drug Chain of Custodyabout 10 years ago
Data Unleashed: Cooperation Among Competitorsabout 10 years ago
Raising the Stakes On Value-Based Pricingabout 10 years ago
The Diversity Dearth in Pharmaabout 10 years ago
Information in Action: A Conversation with Barbara Lopez Kunzabout 10 years ago
R&D Model Mixes Compassion, Calculationabout 10 years ago
Pressure Builds to Revamp Off-Label Marketing Rulesabout 10 years ago
Drug Compounding: A Cause and Cure for High Drug Prices?about 10 years ago
The Odd Coupleabout 10 years ago
Country Report: EgyptNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Teva Enters $900 Million Agreement to Acquire Emalex
4
Pharmaceutical Risks in the Strait of Hormuz
5